Sally Evans Selected Research

4- benzyloxy- 3,5- dimethoxy- N- (1- (dimethylaminocyclopently)methyl)benzamide

1/2022

Peripheral Administration of Selective Glycine Transporter-2 Inhibitor, Oleoyl-D-Lysine, Reverses Chronic Neuropathic Pain but Not Acute or Inflammatory Pain in Male Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sally Evans Research Topics

Disease

1	Acute Pain 01/2022
1	Chronic Pain 01/2022
1	Hyperalgesia 01/2022
1	Neuralgia (Stump Neuralgia) 01/2022
1	Pain (Aches) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Overweight 02/2003

Drug/Important Bio-Agent (IBA)

1	Glycine Plasma Membrane Transport ProteinsIBA 01/2022
1	Opiate AlkaloidsIBA 01/2022
1	4- benzyloxy- 3,5- dimethoxy- N- (1- (dimethylaminocyclopently)methyl)benzamideIBA 01/2022
1	Freund's AdjuvantIBA 01/2022
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2022
1	LipidsIBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Orlistat (Xenical)FDA Link 02/2003

Therapy/Procedure

1	Analgesia 01/2022
1	Kidney Transplantation 02/2003
1	Peritoneal Dialysis 02/2003